Pharmaceutical Product Development’s $550 Million Recapitalization With Existing Owners and New Investors

Simpson Thacher is representing Hellman & Friedman in connection with its entering into definitive agreements to recapitalize Pharmaceutical Product Development, LLC Under the agreements, Hellman &…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Ambrogio Visconti

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here